Skip to main content

Want a detailed portfolio tracker?

Pliant Therapeutics (PLRX) P/E (2020 - 2026)

Pliant Therapeutics (PLRX) P/E from Jun 30, 2020 to Jun 12, 2026. The TTM Pliant Therapeutics (PLRX) P/E is -0.61. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pliant Therapeutics (PLRX)

YearP/EChange
2026-0.61+22.38%
2025-0.50-86.79%
2024-3.80-42.53%
2023-6.61-0.84%
2022-6.66+33.62%
2021-4.99-67.49%
2020-15.34N/A

Comparison Pliant Therapeutics (PLRX) P/E with competitors

Pliant Therapeutics (PLRX) P/E is -0.61.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.28%
NBYStablecoin Development Corp0.00-100.70%
ENLVEnlivex Therapeutics Ltd0.13-121.05%
FGENFibroGen Inc0.24-139.10%
TRAWTraws Pharma Inc0.47-177.02%
FBIOFortress Biotech Inc0.71-215.41%
CHRSCoherus Biosciences Inc0.80-230.55%
ORMPOramed Pharmaceuticals Inc1.37-323.12%
AGENAgenus Inc1.84-400.42%
VIVSVivoSim Labs Inc2.32-477.83%
INVAInnoviva Inc3.31-639.82%
CRMDCorMedix Inc3.78-715.63%
VXRTVaxart Inc3.95-743.68%
ABEOAbeona Therapeutics Inc3.96-745.25%
SRPTSarepta Therapeutics Inc4.19-782.35%
CVACCureVac N.V.4.45-824.17%
GLPGGalapagos NV4.86-891.48%
ABUSArbutus Biopharma Corp5.06-923.54%
RIGLRigel Pharmaceuticals5.16-940.24%
CGENCompugen Ltd5.24-954.18%
ZVRAZevra Therapeutics Inc6.13-1098.93%
OMEROmeros Corporation9.11-1583.46%
PLXProtalix BioTherapeutics Inc9.21-1599.97%
SPROSpero Therapeutics Inc9.31-1615.90%
AUPHAurinia Pharmaceuticals Inc9.32-1618.67%
ACADAcadia Pharmaceuticals Inc9.62-1666.30%
TBPHTheravance Biopharma Inc11.86-2031.36%
ADMAAdma Biologics Inc12.13-2076.24%
SABSSAB Biotherapeutics Inc12.93-2205.51%
HRMYHarmony Biosciences Holdings Inc14.05-2388.65%
REGNRegeneron Pharmaceuticals Inc14.36-2438.83%
PBYIPuma Biotechnology Inc14.45-2454.42%
INCYIncyte Corp14.49-2460.17%
NAGENiagen Bioscience Inc14.82-2513.79%
XOMAXOMA Corp14.95-2535.73%
TGTXTG Therapeutics Inc15.67-2653.28%
EXELExelixis Inc16.60-2804.11%
CPRXCatalyst Pharmaceuticals Inc17.36-2927.22%
MDXGMimedx Group Inc17.52-2953.94%
CTMXCytomX Therapeutics Inc19.63-3297.30%
ASNDAscendis Pharma A/S23.50-3928.26%
HALOHalozyme Therapeutics Inc23.83-3981.19%
ARGXArgen X SE24.24-4048.61%
XOMAOXOMA Corp25.34-4228.63%
VRTXVertex Pharmaceuticals Inc25.57-4264.86%
XOMAPXOMA Corp25.67-4281.62%
RPRXRoyalty Pharma plc - Class A27.78-4624.61%
SLNOSoleno Therapeutics Inc29.02-4826.56%
LGNDLigand Pharmaceuticals Inc - Class B31.77-5274.79%
APLSApellis Pharmaceuticals Inc39.02-6456.50%
BMRNBiomarin Pharmaceutical Inc40.22-6651.96%
KRYSKrystal Biotech Inc40.45-6688.57%
ONCBeiGene Ltd58.89-9693.86%
PHARPharming Group N.V.68.77-11303.31%
TECHBio-Techne Corp74.88-12298.74%
VCELVericel Corp87.95-14426.36%
GMABGenmab118.15-19346.02%
ALNYAlnylam Pharmaceuticals Inc123.07-20147.96%
TLXTelix Pharmaceuticals Ltd135.58-22186.14%
CORTCorcept Therapeutics Inc185.65-30341.69%